Explore Here
Treatments

Leukemia Treatment cost in India

The Leukemia Treatment cost in India ranges from $6,000 to $25,000, which is approximately 5,10,000 to 29,80,000 Indian Rupees. The total expense can vary significantly based on various factors such as the type and stage of leukemia, the treatment protocol chosen, the hospital and its facilities, and the patient's overall health condition.


Cost Range of Leukemia Treatment cost in India

Minimum Cost USD 6000
Maximum Cost USD 35000
Total Stay 40 Days
Hospital Stay 20 Days

What is Leukemia?

Leukemia is a type of cancer that starts in the blood-forming tissues, such as the bone marrow. It causes the body to make large numbers of abnormal white blood cells, which don’t work properly. These unhealthy cells crowd out the healthy ones, leading to problems like frequent infections, tiredness, and easy bruising or bleeding. Leukemia can affect people of all ages and often needs treatment like chemotherapy, targeted therapy, or sometimes a bone marrow transplant.

Get a free cost estimate

3 - 50 characters, alphabets and spaces only
Numeric, no spaces or symbols
Explain, 10 - 2000 characters

Who is an eligible candidate for leukemia treatment in India?

1. Medical Eligibility Criteria

a) Confirmed Diagnosis of Leukemia

The patient must have a confirmed diagnosis of leukemia through standardized diagnostic tests, which may include:

  • Complete Blood Count (CBC) with Differential
  • Bone Marrow Aspiration and Biopsy
  • Flow Cytometry
  • Cytogenetic and Molecular Testing (e.g., BCR-ABL for CML)
  • Imaging Tests (CT scans, ultrasound, or X-rays in certain cases)

Classification into subtypes (AML, ALL, CML, CLL) and risk categories is necessary to guide treatment.

b) Type and Progression of Leukemia

  • Acute Leukemia (AML/ALL): Immediate treatment is essential. Most patients with acute leukemia are eligible for chemotherapy and other aggressive therapies, depending on age and organ function.
  • Chronic Leukemia (CML/CLL): May be asymptomatic initially; treatment is based on disease progression, genetic markers, and symptoms.
  • Relapsed or Refractory Leukemia: Patients whose leukemia returns or does not respond to initial treatments may still qualify for advanced options like targeted therapy, immunotherapy, or stem cell transplant.

2. Treatment-Specific Eligibility

a) Chemotherapy Eligibility

  • Standard treatment for most leukemia types.
  • The patient must have adequate organ function (especially liver, kidneys, and heart) to safely receive chemotherapy.
  • May be adapted based on age and performance status (less intensive regimens for elderly patients).

b) Targeted Therapy Eligibility

  • Particularly relevant for patients with specific genetic mutations, such as BCR-ABL (CML), FLT3, IDH1/2 (AML), or TP53.
  • Requires molecular profiling to determine suitability.
  • Patients must be monitored for drug-specific side effects, such as cardiac or liver toxicity.
  • The patient must not have severe immune system deficiencies that could lead to complications.

c) Immunotherapy Eligibility

  • Emerging options for relapsed or high-risk cases (e.g., CAR-T cell therapy, monoclonal antibodies like blinatumomab).
  • Requires assessment of immune system function and may be offered in specialized centers.
  • Patients should not have active autoimmune diseases or severe infections.

d) Radiation Therapy Eligibility

  • It is used for confined involvement (e.g., lymph node masses, CNS leukemia).
  • It may be used for conditioning prior to stem cell transplantation.
  • In addition to having no contraindicated conditions, candidates must be able to withstand radiation.

e) Stem Cell/Bone Marrow Transplant (SCT/BMT) Eligibility

  • Suitable for high-risk, relapsed, or refractory leukemia.
  • Patients much be below 70 years (some centers accept older patients based on biological age).
  • They should have good organ function (heart, lungs, kidneys, liver).
  • No severe infections or uncontrolled comorbidities.
  • Achieved remission or near remission through prior therapy.
  • Availability of a matched donor (related or unrelated, depending on transplant type).

Begin your medical treatment journey with us

3. General Health & Fitness Criteria

a) Age Criteria

  • Most treatment options are available for patients of all ages, but aggressive treatments like bone marrow transplants are generally recommended for patients under 70 years of age.
  • Some centers may consider older patients based on biological age rather than chronological age (i.e., how healthy they are despite their age).

b) Overall Health Condition

Patients should have a functional status that allows them to tolerate treatment:

  • ECOG Performance Status Score of 0-2 (indicating ability to carry out daily activities with minimal limitations)
  • No severe organ failure (kidney, liver, heart, lungs) that may worsen due to treatment.

c) Organ Function

  • Kidney & Liver Function: Must be within acceptable limits to process and eliminate chemotherapy or targeted therapy drugs.
  • Cardiac Fitness: Patients with heart disease may need cardiac clearance or dose adjustments before initiating treatment.

4. Infection & Immunity Status

  • Patients should not have active infections, as chemotherapy and stem cell transplantation can further weaken the immune system.
  • HIV and Hepatitis B/C patients may require additional evaluation before starting treatment.
Types of Leukemia Treatment in IndiaCost Range in USD
Autologous Bone Marrow Transplant                                 This involves collecting and reinfusing a patient’s own stem cells after intensive chemotherapy or radiation, commonly used to treat blood cancers. 14000 - 16000
Allogeneic Bone Marrow Transplant (BMT)It involves using healthy donor stem cells to replace diseased bone marrow. Recommended for high-risk, relapsed, or aggressive leukemia types. 25000 - 35000
ChemotherapyUses powerful drugs to kill and cancer cells or slow their growth, often as a first-line treatment. 1000 - 1500 per cycle
ImmunotherapyBoosts the immune system to help it recognize and attack leukemia cells.2500 - 3500 per cycle 

Get a free cost estimate

3 - 50 characters, alphabets and spaces only
Eg: 1y3m, 1year, 6 months
Numeric, no spaces or symbols
Explain, 10 - 2000 characters
Allowed Types: doc, docx, pdf, jpg, jpeg

Leukemia Treatment Cost in India Inclusions

  • Treatment as advised 
  • Patient ICU stay and meals during hospitalization
  • Routine drugs and consumables required during hospitalization
  • Hospital stay as needed or advised
  • Meals and stay arrangement for one family member
  • Doctor consultation and daily visits

Leukemia Treatment Cost in India Exclusions

  • Pre-treatment investigations
  • Flights and visa
  • Post-discharge stay
  • Post-treatment follow-ups and medical management
  • Post-treatment dressing and nurse visits
  • Complications management
  • Treatment for any other underlying medical conditions 
  • Any complex investigations or drugs

Begin your medical treatment journey with us Chat Now

Other Factors Affecting Leukemia  Treatment Cost in India

  • Diagnosis of the patient
  • Type of treatment 
  • Choice of location, doctor and hospital
  • Pre-existing medical history
  • Type of chemotherapy drug used for conditioning and maintenance
  • Post-discharge care and medical management needed

Diagnostic Tests Done Before Leukemia Treatment

Types of Tests For Leukemia Treatment in IndiaCost Range in USD
Blood Tests Checks for abnormal M-proteins, kidney function, calcium levels, anemia, and other markers to assess disease severity and organ function. 80-150
Cytogenetic & Molecular TestingDetects chromosomal abnormalities and gene mutations (e.g., BCR-ABL, FLT3, NPM1) that guide targeted therapy. 300-800
Bone Marrow Tests Confirms myeloma by analyzing bone marrow cells and detecting genetic mutations affecting treatment and prognosis. 250-350
Imaging Tests (CT, MRI, Ultrasound)Used to assess organ involvement, lymph node enlargement, or complications such as infections or bleeding. 200-300
Flow CytometryIdentifies the type of leukemia by analyzing surface markers on blood and bone marrow cells 80-150
Additional Pre-Treatment TestsEvaluates heart, lung, and liver function, along with infection screening, to ensure safe treatment planning. 150-250

Begin your medical treatment journey with us Contact Us Now

Why is India Preferred as One of the Best Countries for Leukemia Treatment?

India is increasingly recognized as one of the top global destinations for leukemia treatment, offering a powerful combination of advanced medical care, affordability, and patient-focused support. The country’s cancer care facilities are equipped with modern infrastructure and cutting-edge technologies such as PET-CT, flow cytometry, MRD testing, cytogenetics, and next-generation sequencing (NGS). These tools enable accurate diagnosis and highly personalized treatment plans for all types of leukemia.

Treatment options in India cover the full spectrum, including chemotherapy, targeted therapy, immunotherapy, bone marrow transplant (BMT), and CAR T-cell therapy—delivered at significantly lower costs than in many Western countries. Despite the cost advantage, the quality of care remains on par with global standards. India is home to a large pool of internationally trained hematologists and oncologists with extensive experience in treating both common and rare forms of leukemia. Medical teams in India follow evidence-based protocols and offer multidisciplinary care, ensuring patients receive the best possible outcomes.

What sets India apart is its focus on efficiency and safety. Patients benefit from minimal to no waiting times and strict infection control protocols, which are critical in treating conditions like leukemia. India’s well-developed medical tourism ecosystem supports international patients with visa assistance, language interpretation, accommodation, travel planning, and post-treatment follow-up—making the entire journey smooth and stress-free. With its combination of affordability, expertise, advanced technology, and holistic care, India continues to be a top choice for comprehensive leukemia treatment worldwide.

Best Leukemia Treatment Hospitals in India

Best Hemato-Oncologists For Leukemia Treatment in India

 Dr. Satyendra Katewa
Dr. Satyendra Katewa Consultant - Pediatric Hemato-Oncology and Bone Marrow Transplant Consult Online @ USD 20
Dr. Dharma Choudhary
Dr. Dharma Choudhary Vice Chairman - Hemato Oncology and BMT Book Online Consultation
Dr. Peush Bajpai
Dr. Peush Bajpai HOD - Medical Hemato Oncologist Consult Online @ USD 20
Dr. Divya Bansal
Dr. Divya Bansal Consultant Clinical Hematology Consult Online @ USD 20

Begin your medical treatment journey with us

FAQs

Leukemia is a type of blood cancer that starts in the bone marrow. It happens when the body makes too many abnormal white blood cells, which affect normal blood cell production.

The four major types are:

  • Acute Lymphoblastic Leukemia (ALL)
  • Acute Myeloid Leukemia (AML)
  • Chronic Lymphocytic Leukemia (CLL)
  • Chronic Myeloid Leukemia (CML)

Leukemia treatment in India includes:

  • Chemotherapy – main treatment to kill cancer cells.
  • Targeted therapy – drugs that attack specific cancer cells.
  • Immunotherapy – boosts the body’s immune system.
  • Radiation therapy – used in some cases.
  • Bone marrow or stem cell transplant – for eligible patients.

The success rate depends on the type of leukemia, stage at diagnosis, and age of the patient. With advanced treatments in India, many patients achieve long-term remission, especially with early diagnosis.

Yes, many top hospitals in India treat international patients. Hospitals assist with medical visas, airport pickup, accommodation, translators, and complete patient care.

Yes, India has registered stem cell donor banks. In case a family match is not found, doctors can search for unrelated donors through these registries.

Get a free cost estimate

3 - 50 characters, alphabets and spaces only
Numeric, no spaces or symbols
Explain, 10 - 2000 characters